What are the Major Growth Factors of the Brain Modalities and Software Market?

1
Increasing Elderly population Helping Demand for
Healthcare Supply Chain Management
2
By 2030, the brain modalities and software market
is on the path to produce 23,195.6 million from
13,343.3 million in 2021, growing at a 5.2 CAGR
between 2021 and 2030. This is because of the
increasing patient importance on effective and
early disease diagnosis, growing cases of
neurological ailments, and the surging need for
safer and non-invasive medical imaging. For
example, Alzheimer's Disease International
estimates that 55 million individuals worldwide
will have dementia by 2020. Furthermore, this
number is predicted to rise to 78 million and 139
million by 2030 and 2050, respectively. As the
number of persons with non-communicable
neurological illnesses increase, so does the
amount spent on such treatment. Moreover,
governments will confront a rising need for
rehabilitation, support services, and
neurological disorder treatment as the population
increases. This is owing to the cases of
significant debilitating neurological illnesses
increases dramatically as people become older.
Because most neurological disorders have few
identifiable causes, more study is needed to
create diagnostic, treatment, and preventative
measures.
To receive free sample pages of this report_at_
https//www.psmarketresearch.com/market-analysis/b
rain-modalities-software-market/report-sample
3
In the worldwide brain modalities and software
market, the diagnostic imaging centers segment
will increase at a CAGR of roughly 7 in the
coming years. This is because, as compared to
clinics, hospitals, and other facilities,
diagnostic imaging centers provide more
economical brain monitoring and imaging services.
Shorter wait periods and more customized
treatment are further benefits of approaching a
standalone diagnostic clinic. AI is
progressively used to enhance diagnostic
accurateness and image quality. Moreover, image
excellence enhancement, ailment classification
automation, and segmentation are all instances of
AI advancements in imaging. Thus, advance AI
technologies are available to support
neurosurgeons in making treatment decisions and
analyzing images. AI has evolved in popularity
over the years, and now it is being used in brain
scans to improve image quality, limit the period
a patient spends inside an image scanner, and
enhance decision-making of physician and clinical
analysis.
4
The use of neuroimaging methods such as PETCT,
CT, MRI, PETMRI, and PET for detecting disorders
linked to abnormalities and tumors has accepted
over the years. Brain imaging methods are
required at all phases of the process, from
diagnosis via follow-ups until the end of the
treatment cycle. These brain diagnostic devices
are used for a variety of purposes, including
determining the effects of cysts and tumors,
stroke, and detecting edema and bleeding. Hence,
the demand for brain modalities and software will
grow significantly, due to increasing patient
emphasis on early and effective disease diagnosis.
5
Disclaimer PS Intelligence always keeps its
customers interests at the core while carrying
out research activities. PS Intelligence ensures
the reliability and accuracy of information and
data provided in its market research
publications. However, the information in
publications is subject to fluctuations, as it is
based on primary interviews of officials from
various companies or organizations. PS
Intelligence is not responsible for any incorrect
data provided by the key industry players of the
concerned domain. the information or analysis in
PS Intelligence publications represents opinions
based on research and should not be interpreted
as statements of fact. Information in this report
was believed to be correct at the time of
publication, but cannot be guaranteed. PS
Intelligence does not endorse any product,
service, or vendor depicted in its research
publications. All intellectual properties,
including trademarks and copyrights, belong to
their respective owners and may be protected by
copyright. Under no circumstance can these be
reproduced in any form without prior written
agreement of their owners. An order for market
research report is intended for internal use of
the company only and not for disclosure to third
parties or any other publication in general. No
service, report, or part thereof provided by PS
Intelligence can be reproduced, republished,
resold, revealed, distributed, circulated, or
sublicensed in any medium or form now realized or
hereafter become realized, including but not
limited to, all forms of optical-based media,
magnetic, electronic, or digital, without a
written permission from Prescient Strategic
Intelligence Pvt. Ltd.